Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
292
-
Total 13F shares, excl. options
-
51.5M
-
Shares change
-
+1.05M
-
Total reported value, excl. options
-
$2.16B
-
Value change
-
+$4.78M
-
Put/Call ratio
-
0.67
-
Number of buys
-
161
-
Number of sells
-
-124
-
Price
-
$42.00
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2021
384 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q1 2021.
Editas Medicine, Inc. - Common Stock (EDIT) has 292 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.5M shares
of 82.8M outstanding shares and own 62.25% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (8.75M shares), VANGUARD GROUP INC (6.35M shares), BlackRock Inc. (5.74M shares), Nikko Asset Management Americas, Inc. (4.26M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.22M shares), STATE STREET CORP (2.32M shares), Capital World Investors (1.3M shares), GEODE CAPITAL MANAGEMENT, LLC (1.15M shares), MORGAN STANLEY (966K shares), and JPMORGAN CHASE & CO (965K shares).
This table shows the top 292 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.